text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 2207-75-2 | Product Number: O0164

Potassium Oxonate


Purity: >98.0%(T)(HPLC)
Synonyms:
  • Allantoxanic Acid Potassium Salt
  • Oxonic Acid Potassium Salt
  • Potassium Allantoxanate
  • Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate
Documents:
5G
€30.00
3   28  
25G
€97.00
1   ≥100 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number O0164
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__4H__2KN__3O__4 = 195.18 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 2207-75-2
Related CAS RN 937-13-3
Reaxys Registry Number 4049961
PubChem Substance ID 87574167
MDL Number

MFCD00010565

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Properties (reference)
Melting Point 300 °C
GHS
Related Laws:
EC Number 218-627-5
RTECS# RR4580000
Transport Information:
HS Number 2933698090
Application
Potassium Oxonate: An Inhibitor of Orotate Phosphoribosyltransferase (OPRT)

Potassium oxonate is an inhibitor of orotate phosphoribosyltransferase (OPRT) that is an enzyme involved in the biosynthesis of pyrimidine nucleotides and catalyzes the phosphorylation of 5-FU [F0151] to an active metabolite 5-fluorouridine-5'-monophosphate (FUMP). The gastrointestinal toxicity (GIT) of the oral administration of 5-FU is also caused by the phosphorylation by OPRT in the gut wall. Potassium oxonate selectively and competitively inhibits OPRT. As a result, 5-FU associated gastrointestinal toxic effects are reduced. Potassium oxonate is often used as combined agents to enhance the antitumor activity of fluoropyrimidines, such as S-1 (tegafur [F0635] a prodrug of 5-FU, gimeracil [C2243] and potassium oxonate at a molar ratio of 1:0.4:1). (The product is for research purpose only.)

References


Application
Reagent for hyperuricemia (gout) model

References


PubMed Literature


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.